Logo image of ROVR.CA

ROVER CRITICAL MINERALS CORP (ROVR.CA) Stock Fundamental Analysis

TSX-V:ROVR - TSX Venture Exchange - CA77935R2072 - Common Stock - Currency: CAD

0.22  0 (0%)

Fundamental Rating

1

Taking everything into account, ROVR scores 1 out of 10 in our fundamental rating. ROVR was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of ROVR have multiple concerns. ROVR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ROVR has reported negative net income.
In the past year ROVR has reported a negative cash flow from operations.
In the past 5 years ROVR always reported negative net income.
ROVR had a negative operating cash flow in each of the past 5 years.
ROVR.CA Yearly Net Income VS EBIT VS OCF VS FCFROVR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -1M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA -25.65%
ROE -29.66%
ROIC N/A
ROA(3y)-35.14%
ROA(5y)-44.39%
ROE(3y)-40.03%
ROE(5y)-54.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROVR.CA Yearly ROA, ROE, ROICROVR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100

1.3 Margins

ROVR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ROVR.CA Yearly Profit, Operating, Gross MarginsROVR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

ROVR has more shares outstanding than it did 1 year ago.
ROVR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ROVR has an improved debt to assets ratio.
ROVR.CA Yearly Shares OutstandingROVR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ROVR.CA Yearly Total Debt VS Total AssetsROVR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

2.2 Solvency

Based on the Altman-Z score of -0.09, we must say that ROVR is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.03 indicates that ROVR is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -0.09
ROIC/WACCN/A
WACCN/A
ROVR.CA Yearly LT Debt VS Equity VS FCFROVR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

2.3 Liquidity

ROVR has a Current Ratio of 0.16. This is a bad value and indicates that ROVR is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.16 indicates that ROVR may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
ROVR.CA Yearly Current Assets VS Current LiabilitesROVR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K

More info and screens

1

3. Growth

3.1 Past

ROVR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -134.14%.
EPS 1Y (TTM)-134.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-303.08%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ROVR will show a very strong growth in Earnings Per Share. The EPS will grow by 23.86% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y90%
EPS Next 2Y37.84%
EPS Next 3Y23.86%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ROVR.CA Yearly EPS VS EstimatesROVR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ROVR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ROVR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ROVR.CA Price Earnings VS Forward Price EarningsROVR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 -5 10 15 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ROVR.CA Per share dataROVR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

A more expensive valuation may be justified as ROVR's earnings are expected to grow with 23.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.84%
EPS Next 3Y23.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ROVR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROVER CRITICAL MINERALS CORP

TSX-V:ROVR (5/8/2025, 7:00:00 PM)

0.22

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)04-25 2025-04-25
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners27.33%
Ins Owner ChangeN/A
Market Cap2.67M
Analysts80
Price Target6.32 (2772.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)900%
PT rev (3m)900%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 0.59
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS0.37
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.65%
ROE -29.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-35.14%
ROA(5y)-44.39%
ROE(3y)-40.03%
ROE(5y)-54.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z -0.09
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-134.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-303.08%
EPS Next Y90%
EPS Next 2Y37.84%
EPS Next 3Y23.86%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.33%
EBIT Next 3Y2.17%
EBIT Next 5YN/A
FCF growth 1Y72.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.75%
OCF growth 3YN/A
OCF growth 5YN/A